ODTX

Conviction 94HealthcareScan · Thu, Sep 24, 2026

Odyssey Therapeutics, Inc. (ODTX) closed at $19.98 (-3.76%) on Sep 24, 2026. Price is below its 50-day. RSI(14) 39, -30.5% from its 52-week high, +21.7% year to date. Sector: Healthcare · Biotechnology.

ODTX$19.98-3.76%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 550.98K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Odyssey Therapeutics, Inc.Biotechnologywww.odysseytx.com ↗

Price19.98

Change-3.76%

Gap+1.59%

Rel volume3.69×

Avg volume433.83K

Avg $ vol10.21M

SMA 2024.25

SMA 5022.11

SMA 200—

Price vs 50-9.65%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 26.61

RSI (14)39

MACD hist-0.67

MACD cross—

Stoch %K / %D12 / 12

ADX (14)27

+DI / −DI16 / 26

RSI divergence—

MACD divergence—

ATR %10.79%

ADR %8.96%

52w high28.76

52w low15.56

From 52w high-30.53%

Above 52w low+28.41%

New 52w highNo

SqueezeOff

Bollinger width33.36%

%B-0.03

Donchian pos11.68%

Donchian high29.05

Donchian low18.78

AVWAP (52w high)23.34

vs AVWAP high-14.38%

AVWAP (52w low)21.55

vs AVWAP low-7.31%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d3.69×

Avg vol (14d)550.98K

Avg vol (20d)433.83K

Avg $ vol (20d)10.21M

Market cap960.21M

RS Rating—

RS 3m (vs SPY)+7.76%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank14.3

1 week-13.95%

1 month-23.83%

3 months+12.25%

6 months—

1 year—

YTD+21.68%

P/E—

P/B2.28

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current11.36

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target34.33

Target upside71.82%

Analyst ratingBuy

Institutional72.61%

Ent. value878.18M

Revenue0

Net income-52.79M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out44.99M

Employees—

ListedFri, May 8, 2026

Free float23.66M

Float %49.2%

Short interest2.21M

Days to cover12.8d

Short volume85.3%

Squeeze score79 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.26 vs −$0.83

Last surprise-51.8% miss

Setup gradeA+

Conviction94 / 100

Pattern quality—

Tech rank14.3 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance28.53

Support19.95

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ODTX

All disclosures →

No recent disclosed trades by Congress in ODTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ODTX · open-market 1 buy

Insider	Side	Shares	Value	Traded	Filed
TPG GP A, LLC Insider · Common Stock · 2026-05-11	Buy	1.39M	$25M	2026-05-11	2026-05-13
WINKELRIED JON Insider · Common Stock · 2026-05-11	Dispose	2.35K	$42K	2026-05-11	2026-05-13
COULTER JAMES G Insider · Common Stock · 2026-05-11	Acquire	423.11K	—	2026-05-11	2026-05-13
TPG GP A, LLC Insider · Common Stock · 2026-05-11	Dispose	2.35K	$42K	2026-05-11	2026-05-13
WINKELRIED JON Insider · Common Stock · 2026-05-11	Acquire	423.11K	—	2026-05-11	2026-05-13
COULTER JAMES G Insider · Warrants (right to buy) · 2026-05-11	Dispose	423.11K	—	2026-05-11	2026-05-13
TPG GP A, LLC Insider · Warrants (right to buy) · 2026-05-11	Dispose	423.11K	—	2026-05-11	2026-05-13
WINKELRIED JON Insider · Common Stock · 2026-05-11	Convert	1.88M	—	2026-05-11	2026-05-13
COULTER JAMES G Insider · Common Stock · 2026-05-11	Dispose	2.35K	$42K	2026-05-11	2026-05-13
COULTER JAMES G Insider · Series D Preferred Stock · 2026-05-11	Convert	18.27M	—	2026-05-11	2026-05-13

SEC filings

EDGAR filings in ODTX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.